These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28101210)

  • 1. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells.
    Gong YQ; Peng D; Ning XH; Yang XY; Li XS; Zhou LQ; Guo YL
    Oncol Lett; 2016 Dec; 12(6):4485-4492. PubMed ID: 28101210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
    Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
    Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
    Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
    Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
    Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
    Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway.
    Liu Y; Ji W; Yue N; Zhou W
    Open Life Sci; 2021; 16(1):1082-1090. PubMed ID: 34703898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T knockdown inhibits gastric cancer progression.
    Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
    Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma.
    Liu LL; Zhu JM; Yu XN; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Wu J; Shen XZ
    Cancer Manag Res; 2019; 11():8359-8370. PubMed ID: 31571992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation.
    Luo M; Zhou Y
    Oncol Lett; 2021 Oct; 22(4):714. PubMed ID: 34457069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2T silencing inhibited non-small cell lung cancer cell proliferation and invasion by suppressing the wnt/β-catenin signaling pathway.
    Liu J; Liu X
    Int J Clin Exp Pathol; 2017; 10(9):9482-9488. PubMed ID: 31966822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer.
    Zhu X; Li T; Niu X; Chen L; Ge C
    Oncol Lett; 2020 Oct; 20(4):44. PubMed ID: 32802166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of UBE2T in lung cancer tumors and cell lines.
    Hao J; Xu A; Xie X; Hao J; Tian T; Gao S; Xiao X; He D
    Tumour Biol; 2008; 29(3):195-203. PubMed ID: 18667844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress.
    Dutta R; Guruvaiah P; Reddi KK; Bugide S; Reddy Bandi DS; Edwards YJK; Singh K; Gupta R
    NAR Cancer; 2022 Dec; 4(4):zcac035. PubMed ID: 36338541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.
    Machida YJ; Machida Y; Chen Y; Gurtan AM; Kupfer GM; D'Andrea AD; Dutta A
    Mol Cell; 2006 Aug; 23(4):589-96. PubMed ID: 16916645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
    Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of
    Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A
    Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678
    [No Abstract]   [Full Text] [Related]  

  • 20. High expression of UBE2T predicts poor prognosis and survival in multiple myeloma.
    Zhang W; Zhang Y; Yang Z; Liu X; Yang P; Wang J; Hu K; He X; Zhang X; Jing H
    Cancer Gene Ther; 2019 Nov; 26(11-12):347-355. PubMed ID: 30622320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.